HB 1509 Florida House · 2023 Regular Session

Prescription Drugs

Summary

Prescription Drugs; Requires drug manufacturers to notify DBPR of reportable drug price increases; prohibits manufacturers from claiming public records exemption for trade secrets for information provided in forms or reports; requires DFS to designate employee as primary contact on issues relating to PBMs; provides penalty for persons who do not hold certificate of authority to act as administrator; requires PBMs to identify ownership affiliations to office; provides requirements for contracts between PBM & participating pharmacy; provides for biennial examinations of PBMs. APPROPRIATION: $1,127,525

Bill status in committee 3 of 5 stages cleared

Introduction

Mar 2023

Committee Review

Apr 2023

House Passage

Apr 2023

Senate Passage

Governor

Introduced Mar 6, 2023 Last action May 1, 2023

Floor votes · House Apr 24, 2023

How they voted

20–0

Passed · 1 other

Total votes 21

Apr 24, 2023

D Democratic6

6 Yea

100% Yea

R Republican15

14 Yea 1

93% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 25, 2023

Committee

Bill referred to House Calendar

lower

Apr 24, 2023

House · Passed

House Vote: pass (20-0-1)

house

Apr 24, 2023

Lower · Passed

Reported out of Health & Human Services Committee

lower

Apr 24, 2023

Lower · Passed

Favorable with CS by Health & Human Services Committee

lower

Apr 23, 2023

Lower · Passed

Added to Health & Human Services Committee agenda

lower

Apr 22, 2023

Lower · Passed

Now in Health & Human Services Committee

lower

Apr 22, 2023

Committee

Referred to Health & Human Services Committee

lower

Apr 21, 2023

Lower · Passed

Reported out of Appropriations Committee

lower

Apr 21, 2023

Lower · Passed

Favorable with CS by Appropriations Committee

lower

Apr 20, 2023

Lower · Passed

Added to Appropriations Committee agenda

lower

Apr 4, 2023

Lower · Passed

Now in Appropriations Committee

lower

Apr 4, 2023

Committee

Referred to Health & Human Services Committee

lower

Apr 4, 2023

Committee

Referred to Appropriations Committee

lower

Apr 3, 2023

Lower · Passed

Reported out of Healthcare Regulation Subcommittee

lower

Mar 28, 2023

Lower · Passed

Favorable with CS by Healthcare Regulation Subcommittee

lower

Mar 24, 2023

Lower · Passed

Added to Healthcare Regulation Subcommittee agenda

lower

Mar 9, 2023

Lower · Passed

Now in Healthcare Regulation Subcommittee

lower

Mar 9, 2023

Committee

Referred to Health & Human Services Committee

lower

Mar 9, 2023

Committee

Referred to Appropriations Committee

lower

Mar 9, 2023

Committee

Referred to Healthcare Regulation Subcommittee

lower

1 primary · 24 co-sponsors